Hybridization linkers
US-9222082-B2 · Dec 29, 2015 · US
US10000807B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10000807-B2 |
| Application number | US-201615254553-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2016 |
| Priority date | Sep 1, 2016 |
| Publication date | Jun 19, 2018 |
| Grant date | Jun 19, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure describes the effects of transcription mediated from a promoter on the transcription mediated by divergently coupled supercoiling-sensitive promoter. Transcription initiated from a promoter inhibits transcription mediated by a specific supercoiling-sensitive promoter that is divergently coupled to the promoter. A gyrase inhibitor relieves this inhibition and substantially increases the transcription mediated by the specific supercoiling-sensitive promoter that is divergently coupled to another promoter. Accordingly, the invention pertains to a method for identifying a compound as a gyrase inhibitor or not a gyrase inhibitor based on differential expression of genes under the control of divergently coupled promoters in the presence of the compound. Another embodiment of the invention provides an assay for identifying one or more compounds from a library of compounds as a gyrase inhibitor. Polynucleotides and cells containing such polynucleotides that are suitable for carrying out the methods described herein are also provided.
Opening claim text (preview).
We claim: 1. A linear DNA construct comprising: i) a first inducible promoter under the control of an inducer and operably linked to a first gene and at least one terminator, and ii) a second promoter operably linked to a second gene; wherein the first promoter is P T7lac , P trc , P lac , P T7A1/O4 , P lacUV5 , P rhaBAD , P ara , P tetA , P recA , P phoA , P trp , P nar , P PL , P espA , P proU , or P est-4 and the second promoter is P gyrA or P gyrB ; wherein the second promoter is divergently coupled to the first promoter such that: a) the first promoter is located between the second promoter and the first gene; b) the second promoter is located between the first promoter and the second gene; c) at least the first promoter is heterologous to the first gene or the second promoter is heterologous to the second gene; and d) no additional promoter is positioned between the first promoter and the second promoter; wherein, when the linear DNA construct is incorporated in a linear or circular DNA vector or into genomic DNA in a prokaryotic host cell, the first and the second promoters initiate transcription in opposite directions to each other; transcription of the first gene under the control of the first promoter causes negative supercoiling of the second promoter; and said negative supercoiling of the second promoter inhibits transcription of the second gene from the second promoter. 2. The DNA construct of claim 1 , wherein the DNA construct further comprises one or more of: a terminator for the second gene, a selectable marker, an origin of replication for replication in a prokaryotic cell and/or a eukaryotic cell, and a multiple cloning site. 3. The DNA construct of claim 1 , wherein the first gene encodes for a first peptide and the second gene encodes for a second peptide. 4. The DNA construct of claim 1 , wherein only the first gene or only the second gene encodes for a marker protein. 5. A cell or a culture of the cell, wherein the cell comprises the DNA construct of claim 1 . 6. The cell of claim 5 , wherein the cell is a prokaryotic cell. 7. The cell of claim 5 , wherein the construct is incorporated into extra-chromosomal genetic material. 8. The cell of claim 5 , wherein the construct is integrated into the genome of the cell. 9. A linear NA construct comprising: i) a first promoter operably linked to a first gene, and ii) a second promoter operably linked to a second gene; wherein the first promoter is P T7lac , P lac , P T7A1/O4 , or P laCUV5 , and the second promoter is P gyrA or P gyrB ; wherein the second promoter is divergently coupled to the first promoter such that: a) the first promoter is located between the second promoter and the first gene; b) the second promoter is located between the first promoter and the second gene; c) at least the first promoter is heterologous to the first gene or the second promoter is heterologous to the second gene; and d) no additional promoter is positioned between the first promoter and the second promoter; wherein, when the linear DNA construct is incorporated in a linear or circular DNA vector or into genomic DNA in a prokaryotic host cell, the first and the second promoters initiate transcription in opposite directions to each other; transcription of the first gene under the control of the first promoter causes negative supercoiling of the second promoter; and said negative supercoiling of the second promoter inhibits transcription of the second gene from the second promoter. 10. The DNA construct according to claim 1 , wherein the first promoter is separated by no more than 92 bp from the second promoter. 11. The DNA construct according to claim 9 , wherein the first promoter is separated by no more than 92 bp from the second promoter.
Isomerases (5.) · CPC title
on expression patterns · CPC title
DNA topoisomerase (ATP-hydrolysing) (5.99.1.3) · CPC title
involving isomerase · CPC title
for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics (antimicrobial activity C12Q1/18) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.